Physician profile
Steve Mirkos
NPI 1093909657
$5,802.36
in general payments reported to CMS, 2019-2025
16 companies · $706 in 2025
The $706 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,076 · 2020: $485 · 2021: $1,397 · 2022: $141 · 2023: $475 · 2024: $522 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,702.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,143.98 | 2019-2025 | Easyfuse, Augment Injectable, Variax |
| Cardiovascular Systems INC. | $134.72 | 2021 | |
| Smith+Nephew, INC. | $117.51 | 2019-2025 | Hat-Trick, Na |
| Pacira Pharmaceuticals Incorporated | $115.12 | 2019 | |
| Paratek Pharmaceuticals, INC. | $42.49 | 2022-2025 | Nuzyra |
| Arteriocyte Medical Systems, INC. | $36.67 | 2025 | Magellan |
| Bioventus LLC | $35.56 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $28.35 | 2020-2021 | |
| Pfizer INC. | $26.56 | 2019 | |
| Zimmer Biomet Holdings, INC. | $25.99 | 2020 | |
| Averitas Pharma INC. | $19.91 | 2024 | Qutenza |
| Horizon Therapeutics Plc | $16.83 | 2021 | |
| Amgen INC. | $16.44 | 2024 | Krystexxa |
| Paragon 28, INC. | $16.01 | 2019 | |
| Nabriva Therapeutics, Plc | $14.17 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Mirkos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.